Dbv Technologies Is A Clinical Stage Biopharmaceutical Company Based In Bagneuxfrancefounded In 2002 By Pediatricians Drpierre Henri Benhamou And Drchristophe Dupontthe Company Specializes In Developing Innovative Therapies For Food Allergies Using Its Proprietary Viaskinatechnology Platformwhich Employs Epicutaneous Immunotherapyepitto Deliver Allergens Through The Skin The Viaskinaplatform Is A Non Invasive Patch Technology Aimed At Treating Food Allergies By Safely Modulating Allergic Responsesdbv S Pipeline Includes Therapies Targeting Peanutmilkand Egg Allergieswith A Focus On Pediatric Populationsthe Company Collaborates With Healthcare Providersresearchersand Regulatory Bodies To Advance Its Clinical Programswhich Primarily Serve Patients With Severe Food Allergiesdbv Technologies Is Dedicated To Improving The Lives Of Those Affected By Food Allergies Through Effective And Patient Friendly Therapies
